Education
About Us
Working with TipRanks
Follow Us
NKGen Biotech (NKGN)
OTHER OTC:NKGN
Snk01
Moderate Alzheimer Disease
Phase I/II
Recruiting
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
Dec 06, 2023
―
Snk02
Advanced Solid Tumor, Refractory Cancer, Solid Tumor, Advanced Cancer, Metastatic Cancer, Solid Tumor, Adult, Pathologically Confirmed Cancer Refractory To Conventional Therapy, Recurrent Cancer
Phase I
Completed
Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy
Jul 28, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does NKGen Biotech (NKGN) have in its pipeline
NKGN is currently developing the following drugs: Snk01, Snk02. These drug candidates are in various stages of clinical development as the company works toward FDA approval.